Intravitreal Bevacizumab Alone or Combined with Macular Laser Photocoagulation for Recurrent or Persistent Macular Edema Secondary to Branch Retinal Vein Occlusion
Background. To evaluate the efficacy of intravitreal bevacizumab (IVB) injection with or without macular laser photocoagulation (MLP) for recurrent or persistent macular edema (ME) secondary to branch retinal vein occlusion (BRVO). Methods. Thirty-four eyes underwent IVB injection for ME secondary t...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/2014/173084 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849308152762204160 |
|---|---|
| author | Takafumi Hirashima Tomoyuki Chihara Toshitaka Bun Takao Utsumi Miou Hirose Hideyasu Oh |
| author_facet | Takafumi Hirashima Tomoyuki Chihara Toshitaka Bun Takao Utsumi Miou Hirose Hideyasu Oh |
| author_sort | Takafumi Hirashima |
| collection | DOAJ |
| description | Background. To evaluate the efficacy of intravitreal bevacizumab (IVB) injection with or without macular laser photocoagulation (MLP) for recurrent or persistent macular edema (ME) secondary to branch retinal vein occlusion (BRVO). Methods. Thirty-four eyes underwent IVB injection for ME secondary to BRVO as a primary treatment. Twenty of the 34 eyes experienced recurrent or persistent ME after the first IVB. Nine of the 20 eyes (Group 1) were retreated with IVB combined with MLP. The remaining 11 eyes (Group 2) were retreated with IVB alone. Results. In Group 1, the postoperative best corrected visual acuity (BCVA) improved compared with the preoperative value at all follow-up visits, although no statistically significant improvement was observed at 6 months. In contrast, BCVA significantly improved from 0.53 to 0.40 at 6 months (P<0.05) in Group 2. Conclusion. Combined therapy tended to have a smaller effect on visual acuity compared with IVB monotherapy. |
| format | Article |
| id | doaj-art-1454740d2c724626a24bc5ed6d85bfce |
| institution | Kabale University |
| issn | 2090-004X 2090-0058 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Ophthalmology |
| spelling | doaj-art-1454740d2c724626a24bc5ed6d85bfce2025-08-20T03:54:33ZengWileyJournal of Ophthalmology2090-004X2090-00582014-01-01201410.1155/2014/173084173084Intravitreal Bevacizumab Alone or Combined with Macular Laser Photocoagulation for Recurrent or Persistent Macular Edema Secondary to Branch Retinal Vein OcclusionTakafumi Hirashima0Tomoyuki Chihara1Toshitaka Bun2Takao Utsumi3Miou Hirose4Hideyasu Oh5Department of Ophthalmology, Hyogo Prefectural Amagasaki Hospital, 1-1-1 Higashi-daimotsu-cho, Amagasaki, Hyogo 660-0828, JapanDepartment of Ophthalmology, Hyogo Prefectural Amagasaki Hospital, 1-1-1 Higashi-daimotsu-cho, Amagasaki, Hyogo 660-0828, JapanDepartment of Ophthalmology, Hyogo Prefectural Amagasaki Hospital, 1-1-1 Higashi-daimotsu-cho, Amagasaki, Hyogo 660-0828, JapanDepartment of Ophthalmology, Hyogo Prefectural Amagasaki Hospital, 1-1-1 Higashi-daimotsu-cho, Amagasaki, Hyogo 660-0828, JapanDepartment of Ophthalmology, Hyogo Prefectural Amagasaki Hospital, 1-1-1 Higashi-daimotsu-cho, Amagasaki, Hyogo 660-0828, JapanDepartment of Ophthalmology, Hyogo Prefectural Amagasaki Hospital, 1-1-1 Higashi-daimotsu-cho, Amagasaki, Hyogo 660-0828, JapanBackground. To evaluate the efficacy of intravitreal bevacizumab (IVB) injection with or without macular laser photocoagulation (MLP) for recurrent or persistent macular edema (ME) secondary to branch retinal vein occlusion (BRVO). Methods. Thirty-four eyes underwent IVB injection for ME secondary to BRVO as a primary treatment. Twenty of the 34 eyes experienced recurrent or persistent ME after the first IVB. Nine of the 20 eyes (Group 1) were retreated with IVB combined with MLP. The remaining 11 eyes (Group 2) were retreated with IVB alone. Results. In Group 1, the postoperative best corrected visual acuity (BCVA) improved compared with the preoperative value at all follow-up visits, although no statistically significant improvement was observed at 6 months. In contrast, BCVA significantly improved from 0.53 to 0.40 at 6 months (P<0.05) in Group 2. Conclusion. Combined therapy tended to have a smaller effect on visual acuity compared with IVB monotherapy.http://dx.doi.org/10.1155/2014/173084 |
| spellingShingle | Takafumi Hirashima Tomoyuki Chihara Toshitaka Bun Takao Utsumi Miou Hirose Hideyasu Oh Intravitreal Bevacizumab Alone or Combined with Macular Laser Photocoagulation for Recurrent or Persistent Macular Edema Secondary to Branch Retinal Vein Occlusion Journal of Ophthalmology |
| title | Intravitreal Bevacizumab Alone or Combined with Macular Laser Photocoagulation for Recurrent or Persistent Macular Edema Secondary to Branch Retinal Vein Occlusion |
| title_full | Intravitreal Bevacizumab Alone or Combined with Macular Laser Photocoagulation for Recurrent or Persistent Macular Edema Secondary to Branch Retinal Vein Occlusion |
| title_fullStr | Intravitreal Bevacizumab Alone or Combined with Macular Laser Photocoagulation for Recurrent or Persistent Macular Edema Secondary to Branch Retinal Vein Occlusion |
| title_full_unstemmed | Intravitreal Bevacizumab Alone or Combined with Macular Laser Photocoagulation for Recurrent or Persistent Macular Edema Secondary to Branch Retinal Vein Occlusion |
| title_short | Intravitreal Bevacizumab Alone or Combined with Macular Laser Photocoagulation for Recurrent or Persistent Macular Edema Secondary to Branch Retinal Vein Occlusion |
| title_sort | intravitreal bevacizumab alone or combined with macular laser photocoagulation for recurrent or persistent macular edema secondary to branch retinal vein occlusion |
| url | http://dx.doi.org/10.1155/2014/173084 |
| work_keys_str_mv | AT takafumihirashima intravitrealbevacizumabaloneorcombinedwithmacularlaserphotocoagulationforrecurrentorpersistentmacularedemasecondarytobranchretinalveinocclusion AT tomoyukichihara intravitrealbevacizumabaloneorcombinedwithmacularlaserphotocoagulationforrecurrentorpersistentmacularedemasecondarytobranchretinalveinocclusion AT toshitakabun intravitrealbevacizumabaloneorcombinedwithmacularlaserphotocoagulationforrecurrentorpersistentmacularedemasecondarytobranchretinalveinocclusion AT takaoutsumi intravitrealbevacizumabaloneorcombinedwithmacularlaserphotocoagulationforrecurrentorpersistentmacularedemasecondarytobranchretinalveinocclusion AT miouhirose intravitrealbevacizumabaloneorcombinedwithmacularlaserphotocoagulationforrecurrentorpersistentmacularedemasecondarytobranchretinalveinocclusion AT hideyasuoh intravitrealbevacizumabaloneorcombinedwithmacularlaserphotocoagulationforrecurrentorpersistentmacularedemasecondarytobranchretinalveinocclusion |